These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 31111736)

  • 1. The Genetically Modified Organism Medicinal Framework in Europe, United States, and Japan: Underlying Scientific Principles and Considerations Toward the Development of Gene Therapy and Genetically Modified Cell-Based Products.
    Bachtarzi H; Farries T
    Hum Gene Ther Clin Dev; 2019 Sep; 30(3):114-128. PubMed ID: 31111736
    [No Abstract]   [Full Text] [Related]  

  • 2. Call for More Effective Regulation of Clinical Trials with Advanced Therapy Medicinal Products Consisting of or Containing Genetically Modified Organisms in the European Union.
    Beattie S;
    Hum Gene Ther; 2021 Oct; 32(19-20):997-1003. PubMed ID: 33843251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of GMO regulatory requirements for AAV vectors in the EU and Japan focusing on the shedding data and containment measures.
    Mizoguchi H; Fleischmann T; Komuro M; Hirai T; Ikeda A; Saito K; Watahiki T; Tajima G
    Expert Opin Biol Ther; 2024 Jun; 24(6):529-542. PubMed ID: 38919146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulations governing veterinary medicinal products containing genetically modified organisms in the European community.
    Moulin G
    Rev Sci Tech; 2005 Apr; 24(1):101-7. PubMed ID: 16110880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The EU regulatory framework on genetically modified organisms (GMOs).
    Bruetschy C
    Transgenic Res; 2019 Aug; 28(Suppl 2):169-174. PubMed ID: 31321701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental risk assessment for medicinal products containing genetically modified organisms.
    Anliker B; Longhurst S; Buchholz CJ
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jan; 53(1):52-7. PubMed ID: 19940966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hurdles of environmental risk assessment procedures for advanced therapy medicinal products: comparison between the European Union and the United States.
    Iglesias-Lopez C; Obach M; Vallano A; Agustí A; Montané J
    Crit Rev Toxicol; 2019 Aug; 49(7):580-596. PubMed ID: 31846383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Off-label prescription of genetically modified organism medicines in europe: emerging conflicts of interest?
    Schagen FH; Hoeben RC; Hospers GA
    Hum Gene Ther; 2014 Oct; 25(10):893-6. PubMed ID: 25268158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Options to Reform the European Union Legislation on GMOs: Scope and Definitions.
    Eriksson D; Custers R; Edvardsson Björnberg K; Hansson SO; Purnhagen K; Qaim M; Romeis J; Schiemann J; Schleissing S; Tosun J; Visser RGF
    Trends Biotechnol; 2020 Mar; 38(3):231-234. PubMed ID: 32059122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of genetically modified organism requirements on gene therapy development in the EU, Japan, and the US.
    Tajima G; Huh S; Schmidt NA; Macdonald JC; Fleischmann T; Wonnacott KM
    Mol Ther Methods Clin Dev; 2022 Sep; 26():74-83. PubMed ID: 35782596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporary derogation from European environmental legislation for clinical trials of genetically modified organisms for coronavirus disease 2019.
    Iglesias-Lopez C
    Cytotherapy; 2021 Jan; 23(1):10-11. PubMed ID: 33082093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EFSA's scientific activities and achievements on the risk assessment of genetically modified organisms (GMOs) during its first decade of existence: looking back and ahead.
    Devos Y; Aguilera J; Diveki Z; Gomes A; Liu Y; Paoletti C; du Jardin P; Herman L; Perry JN; Waigmann E
    Transgenic Res; 2014 Feb; 23(1):1-25. PubMed ID: 23963741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A decade of marketing approval of gene and cell-based therapies in the United States, European Union and Japan: An evaluation of regulatory decision-making.
    Coppens DGM; de Wilde S; Guchelaar HJ; De Bruin ML; Leufkens HGM; Meij P; Hoekman J
    Cytotherapy; 2018 Jun; 20(6):769-778. PubMed ID: 29730080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Options to Reform the European Union Legislation on GMOs: Risk Governance.
    Eriksson D; Custers R; Edvardsson Björnberg K; Hansson SO; Purnhagen K; Qaim M; Romeis J; Schiemann J; Schleissing S; Tosun J; Visser RGF
    Trends Biotechnol; 2020 Apr; 38(4):349-351. PubMed ID: 32171418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy legislation in The Netherlands.
    Bleijs DA; Haenen IT; Bergmans JE
    J Gene Med; 2007 Oct; 9(10):904-9. PubMed ID: 17721872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environmental risk assessment of advanced therapies containing genetically modified organisms in the EU.
    Whomsley R; Palmi Reig V; Hidalgo-Simon A
    Br J Clin Pharmacol; 2021 Jun; 87(6):2450-2458. PubMed ID: 33600022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective.
    Salmikangas P; Schuessler-Lenz M; Ruiz S; Celis P; Reischl I; Menezes-Ferreira M; Flory E; Renner M; Ferry N
    Adv Exp Med Biol; 2015; 871():103-30. PubMed ID: 26374215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Traceability of genetically modified organisms.
    Aarts HJ; van Rie JP; Kok EJ
    Expert Rev Mol Diagn; 2002 Jan; 2(1):69-76. PubMed ID: 11963810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversy over genetically modified organisms: the governing laws and regulations.
    Keatley KL
    Qual Assur; 2000; 8(1):33-6. PubMed ID: 11710306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Databases on biotechnology and biosafety of GMOs.
    Degrassi G; Alexandrova N; Ripandelli D
    Environ Biosafety Res; 2003; 2(3):145-60. PubMed ID: 15612413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.